1. Regulatory Specifications: Whether It May Be Used At All

This group is the most frequently skipped and the most capable of ruining a project. No matter how high the assay, a material whose botanical origin falls outside the permitted list cannot be sold.

1.1 Only two species are official; the rest are adulterants

The Chinese Pharmacopoeia defines the drug as the dried fleshy stem, bearing scale leaves, of Cistanche deserticola Y. C. Ma (commonly called desert cistanche) or Cistanche tubulosa (Schrenk) Wight (commonly called Xinjiang cistanche). The latter was admitted to the pharmacopoeia in the 2005 edition. The genus in China comprises four species and one variety. Cistanche salsa, Cistanche salsa var. albiflora and Cistanche sinensis are not official, and Boschniakia rossica is a separate regional substitute rather than a pharmacopoeial article.

1.2 The food-use line: only the desert species is listed

Announcement No. 9 of 2023, issued by the National Health Commission and the State Administration for Market Regulation, added nine substances, including Cistanche, to the catalogue of materials traditionally used both as food and as Chinese medicinals. The catalogue entry reads Cistanche (desert), with the Latin name Cistanche deserticola Y. C. Ma and the part given as the fleshy stem.

Cistanche deserticola Y.C.Ma

1.3 Evidence of lawful sourcing

Wild Cistanche is a Class II nationally protected wild plant in China and has been listed under the Convention on International Trade in Endangered Species. Today Cistanche tubulosa is cultivated mainly in southern Xinjiang, while Cistanche deserticola is inoculated and cultivated at scale in Inner Mongolia, Gansu and Ningxia. Purchasers should require documentation of the cultivation base or harvest source, and proof of artificial cultivation, to avoid exposure to illegal wild collection.

2. Identity and Authenticity: Origin and Cross-Section Reveal Adulteration

Adulteration is a real and measured risk in this botanical. In a nationwide sampling of Cistanche decoction pieces, eleven of twelve batches that failed morphological examination were Cistanche sinensis, and one further batch was adulterated with it, giving an adulteration rate near eighteen percent.

Table 1 Identification points for official species and common adulterants

Species	Status	Vascular bundle pattern on cut surface	Other distinguishing features
Cistanche deserticola	Official; listed in the food catalogue	Dot-like bundles arranged in a deeply wavy ring	Flattened cylindrical and slightly curved; densely covered with imbricate fleshy scale leaves; heavy, hard, slightly flexible; faint odor, sweet then slightly bitter; about five bundles in the scale leaf
Cistanche tubulosa	Official since 2005	Dot-like bundles scattered across the whole cut surface	Flattened fusiform or irregular, often twisted; hard and inelastic, granular fracture; produced mainly in southern Xinjiang
Cistanche salsa	Not official (regional use in Xinjiang and Inner Mongolia)	Shallow wavy ring, hard to distinguish from the official species	Thinner scale leaves; slightly salty and bitter; about ten bundles in the scale leaf
Cistanche sinensis	Not official; frequent in sampling failures	Subpolygonal arrangement	Slender; thicker scale leaves, four to six per whorl; pale yellow bundles on the cut surface
Boschniakia rossica	Regional substitute, not pharmacopoeial	Not applicable	Single erect slender stem with the spicate inflorescence left on the apex; easily separated from the official species

Once the material has been extracted, the sliced morphology no longer exists, and morphological identification fails. At that point, the following should be relied upon:

Cistanche tubulosa (Schrenk) Wight

Characteristic chemical markers: 2'-acetylacteoside distinguishes Cistanche deserticola from Cistanche tubulosa; the presence of poliumoside and 2'-acetylpoliumoside indicates Cistanche sinensis and signals adulteration.

HPLC fingerprint or characteristic chromatogram: requires a profile compared against a reference crude drug, not merely the quantitation of two peaks.

Thin-layer identification: using echinacoside and acteoside as reference substances, as a minimum level of identity control.

3. Core Assay Specifications: Two Compounds and Their Passing Lines

3.1 Statutory limits

Under the Cistanche monograph of the Chinese Pharmacopoeia, determined by HPLC and calculated on the dried basis, Cistanche deserticola must contain not less than 0.30 percent of the combined amount of echinacoside and acteoside, while Cistanche tubulosa must contain not less than 1.5 percent.

Main Chemical Constituents of Cistanche tubulosa

3.2 Methodological details worth checking on a certificate

Table 2 Pharmacopoeial HPLC conditions and how to read results

Item	Stipulated condition	Where acceptance goes wrong
Column	Octadecylsilane bonded silica	Retention times shift between brands; judge on resolution, not on absolute times
Mobile phase	Methanol and 0.1 percent formic acid, gradient elution	Results from an acetonitrile system, used in some granule standards, are not directly comparable
Detection wavelength	330 nm	This is the characteristic absorbance of phenylethanoid glycosides; a shifted wavelength distorts results
System suitability	Not fewer than 3000 theoretical plates for the echinacoside peak	A report that omits this leaves the method's reliability in doubt
Sample preparation	50 percent methanol, 30 minutes standing, 40 minutes sonication at 250 W and 35 kHz	Incomplete extraction underestimates content; power and time are real variables
Basis of calculation	Calculated on the dried basis	A result not corrected for moisture will read low; check that the basis is stated

3.3 How to read commercial extract specifications

Table 3 Common specification labels and how to interpret them

Label	Meaning	Typical method	Risk and interpretation
10:1, 20:1, 30:1	Concentration ratio, kilograms of crude drug per kilogram of extract	Usually no assay, a process description only	Implies nothing about active content; cannot be used to compare quotations and should never be the sole criterion
Total glycosides 20 to 85 percent	Total phenylethanoid glycosides	UV spectrophotometry	UV measures total absorbance against a single reference and is inflated by co-occurring phenolics; values run systematically above HPLC sums
Echinacoside 5 to 80 percent	A single constituent	HPLC	Most reliable, but reflects one compound; should be read together with acteoside
Acteoside 10 to 95 percent	A single constituent	HPLC	At the top of the range the material approaches a chemical reference standard; confirm it is still genuinely an extract
Total glycosides 40 percent plus echinacoside 10 percent	Combined declaration	UV and HPLC together	The better practice, as the two methods cross-check each other

Cistanche tubulosa experiment

4. Synergy Specifications: The Half That Standards Ignore and Research Confirms

This is the category this article most wants to emphasize. Work on antidepressant activity has shown clearly that neither the abundant phenylethanoid glycosides nor the scarce iridoid glycosides work well alone; only the combination produces a significant effect. Tracking two glycosides alone discards half the picture systematically.

Table 4 Additional constituents worth including in internal specifications

Compound class	Representative substances	Why it matters	Suggested form of specification
Phenylethanoid glycosides	Echinacoside, acteoside, isoacteoside, tubuloside A and B, 2'-acetylacteoside	Recognized as the core active class and the statutory markers	Quantify two markers by HPLC; control the ratio of remaining peaks in a characteristic chromatogram
Iridoid glycosides	8-epiloganic acid, geniposidic acid, 8-epideoxyloganic acid	Synergize with phenylethanoid glycosides in antidepressant models; rank high in spectrum-effect work on diabetic kidney disease	Quantify one or two representative peaks by HPLC or UPLC-MS
Polysaccharides	Cistanche deserticola polysaccharides	Immunomodulation and laxation; improve diabetic nephropathy through gut microbiota and inhibition of TLR4/NF-kB	Crude polysaccharide by the phenol-sulfuric acid method; regional standards commonly require not less than 3.0 percent
Oligosaccharides and betaine	Betaine, oligosaccharides	Betaine resembles choline and probably acts as a cholinomimetic, an important part of the laxative mechanism; content rises after wine processing	Betaine by HPLC; regional standards commonly require not less than 1.5 percent
Sugar alcohols	Mannitol	Characteristic of Cistanche deserticola; useful as a secondary check on botanical origin and adulteration	Regional standards require mannitol not less than 6.0 percent
Lignans	Pinoresinol and related compounds	Potential contributors to antioxidant and antitumor activity	Research stage; observe as fingerprint peaks for now

Regional and group standards have already moved in this direction. A group standard from Alxa requires a combined echinacoside and acteoside content of not less than 0.5 percent, crude polysaccharide not less than 3.0 percent, and betaine not less than 1.5 percent. An Inner Mongolia regional standard additionally requires protein not less than 10.0 percent, mannitol not less than 6.0 percent, and extractives not less than 45.0 percent. Such multi-dimensional criteria describe real quality far better than two glycosides alone and deserve a place in internal specifications.

Cistanche tubulosa extract

Click here to view Cistanche Tubulosa Extract Natural Supplement Powder

【Ask for more】 Email:cindy.xue@wecistanche.com / WhatsApp: 0086 18599088692 / WeChat: 18599088692

5. Routine Physicochemical Specifications

Table 5 Routine physicochemical parameters across crude drug, food material and extract

Parameter	Pharmacopoeia (crude drug)	Regional or group standards (food material)	Additional points for extracts
Moisture	Not more than 10.0 percent	Slices not more than 10.0 percent; powder not more than 5.0 percent	Extracts are hygroscopic; not more than 5.0 percent is advisable, and moisture is also the basis for the dried-basis calculation of assay
Total ash	Not more than 8.0 percent	Not more than 8.0 percent	High values suggest soil, inorganic matter or incompletely washed rhizosphere material from the host plant
Extractives	Cold maceration in dilute ethanol: not less than 35.0 percent for deserticola, 25.0 percent for tubulosa	Not less than 45.0 percent in some standards	For extracts, water-soluble extractives may be substituted; note that the pharmacopoeial limits differ by species
Acid-insoluble ash	Not listed separately	Not specified	Recommended as an internal control because it reflects silicate soil contamination more specifically
Particle size	Not applicable	Powder must pass entirely through a 180 micrometer sieve	Commercial powders are commonly 80 to 100 mesh; spray-dried powders should also be assessed for flow and bulk density
Appearance and color	Not applicable	Yellow-brown to brown, uniform, free of mold	State whether spray drying or vacuum drying was used; abnormal color suggests overheating or oxidation
Water solubility	Not applicable	Not specified	For beverage applications, require full solubility in water and absence of heavy sediment after cold dissolution

6. Safety Specifications: Limits Depend on Intended Use

These items must be checked one by one, and they are the ones most often copied across from an unrelated document. Limits differ between standards according to product category and jurisdiction.

Table 6 Contaminant and residue limits compared

Item	Food catalogue (Announcement No. 9, 2023)	Gansu DBS 62/009	Alxa group standard	Inner Mongolia DB15/T 2360
Lead	Not more than 1.0 mg/kg	Not more than 0.9 mg/kg	Not more than 0.8 mg/kg	Not more than 1.0 mg/kg
Cadmium	Not more than 0.5 mg/kg	Not more than 0.4 mg/kg	Not more than 0.5 mg/kg	Not more than 0.2 mg/kg
Total arsenic	Not more than 0.5 mg/kg	Not more than 0.4 mg/kg	Not more than 0.5 mg/kg	Not more than 0.5 mg/kg
Total mercury	Not more than 0.1 mg/kg	Not more than 0.1 mg/kg	Not more than 0.1 mg/kg	Not more than 0.2 mg/kg
Sulfur dioxide residue	Not more than 400 mg/kg	Not more than 100 mg/kg	Not specified	Not specified
Aflatoxin B1	Not specified	Not more than 10.0 micrograms/kg	Not specified	Not more than 5.0 micrograms/kg
Pesticide residues	Must meet the relevant provisions of the Ministry of Agriculture and Rural Affairs	Must meet GB 2763	Not specified	Trichlorfon 0.01, carbendazim 0.1, phoxim 0.05, deltamethrin 0.01, omethoate 0.01, all in mg/kg

Beyond these, an extract requires items that crude drug standards do not cover but which are critical for extracts:

Residual solvents: most commercial material is extracted with ethanol and water; control ethanol and any other organic solvent according to GB 5009.262 or an internal limit. Where macroporous adsorption resin is used for purification, resin residues such as benzene and styrene derivatives must also be addressed.

Microbiology: aerobic plate count, coliforms, mold and yeast, and pathogens including Salmonella and Staphylococcus aureus; edible powders are commonly required to meet GB 7101.

Other elements: shipments to the European Union, the United States, and other markets require additional testing against the destination's regulations and pesticide lists.

cistanche powder

7. Processing and Process Specifications: Raw, Wine-Processed and Drying

Whether the starting material is raw or wine-processed determines the chemical profile and the direction of activity. This is a point that extract specifications almost never address, but that purchasers must raise.

Table 7 Differences between raw and wine-processed material

Dimension	Raw Cistanche	Wine-processed Cistanche
Polysaccharide fraction	Retains the original profile	Content decreases after steaming with wine
Oligosaccharides and betaine	Baseline level	Betaine content rises markedly
Phenylethanoid glycosides	Echinacoside and acteoside at original levels	Dissolution improves, but echinacoside and acteoside fall somewhat after steaming while isoacteoside rises
Direction of use	Stronger lubricating action; preferred for constipation from fluid depletion	Stronger kidney-supplementing and yang-assisting action; used for impotence, lumbar pain and infertility
Research evidence	Reference material	Total glycosides from processed material outperformed raw material in restoring HPT axis function, regulating folate and amino acid pathways, and optimizing microbial structure

Drying matters just as much. Cistanche contains glycoside-hydrolyzing enzymes, and if drying is handled poorly, the phenylethanoid glycosides may be hydrolyzed, and content may fall significantly. Purchasers should confirm with the supplier:

Harvest season: dug when the shoot has just emerged in spring or before the ground freezes in autumn, with the stem tip removed, as the pharmacopoeia specifies.

Enzyme deactivation: whether steaming, hot-air drying, or pretreatment before slicing was used to inactivate hydrolytic enzymes.

Extraction and concentration temperature: phenylethanoid glycosides are heat-sensitive and degrade under prolonged high-temperature concentration.

Drying process: spray drying and vacuum drying differ in their effects on color, solubility, and constituent retention.

8. Documentation and Stability: Fixing the Specifications

However carefully specifications are written, they cannot be enforced at acceptance unless they are fixed in contracts and documents. The following should be requested and agreed:

Table 8 Supplier documentation checklist

Document	Required content	What to check
Certificate of analysis	Lot number, Latin binomial of the botanical, part extracted, extraction solvent, specification, HPLC assay, moisture, ash, heavy metals, microbiology, and the standard numbers the testing follows	Whether standard numbers are cited; whether the assay is stated on a dried basis
HPLC characteristic chromatogram or fingerprint	Original chromatogram with the echinacoside and acteoside peaks marked, plus a reference crude drug chromatogram	Similarity against the reference crude drug; look for an anomalous single sharp peak suggesting an added marker compound
Proof of origin and place of production	Cultivation base, host plant, harvest year, evidence of artificial cultivation	For food use, confirm the species is Cistanche deserticola
Process description	Extraction solvent, solid-to-liquid ratio, number of extractions, concentration and drying methods, whether macroporous resin is used	If resin purification is involved, add resin residue testing
Stability and shelf life	Accelerated and long-term data, storage conditions	Commercial shelf life is commonly 24 months; confirm it rests on measured data
Qualification documents	Manufacturing licence, traceability records, third-party re-test reports	Where necessary, send blind samples for independent re-testing

9. Selection by Application: Which Specifications Matter Most

Table 9 Priority of specifications by intended use

Application	Priority	Second priority	May be relaxed
Pharmaceuticals and dispensing granules	Full pharmacopoeial compliance including assay, moisture, ash and extractives; botanical origin and processing specification	Consistency of the characteristic chromatogram; granules must also meet the general requirements for granules and an extractives limit, commonly not less than 20.0 percent	Particle fineness
Health foods and solid beverages	Botanical origin as Cistanche deserticola under the food catalogue; heavy metals, pesticide residues, microbiology and sulfur dioxide	Combined echinacoside and acteoside; betaine and crude polysaccharide	Ratio-style extract labelling
Functional foods for bowel function	Oligosaccharides and betaine; crude polysaccharide; moisture and microbiology	Combined echinacoside and acteoside	Total glycosides by UV
Products for cognition or mood	Accurate HPLC quantitation of echinacoside and acteoside; characteristic chromatogram	Representative iridoid glycoside peaks as evidence of synergy; residual solvents	Crude polysaccharide, which can remain an internal control
Export-oriented material	Destination pesticide and heavy metal lists; solvent and resin residues	Complete certificate of analysis and traceability; third-party re-test	Items specific to domestic regional standards

Cistanche Oral Liquid

Four of the most common purchasing traps

Trap one: judging by ratio alone. A 10:1 label describes a concentration multiple and has no necessary relationship to active content. Two products both labelled 10:1 may differ several-fold in echinacoside.

Trap two: UV total glycosides presented as HPLC assay. UV values are systematically higher and do not distinguish individual compounds. Specify the method at the quotation stage; otherwise, a lower price is merely a smaller number.

Trap three: spiking to manufacture an assay. When the two glycoside peaks are abnormally tall while the rest of the profile is flat and the fingerprint no longer resembles the reference crude drug, suspect an added marker compound. The characteristic chromatogram is the tool that exposes this.

Trap four: mixed or mislabelled botanical origin. Substituting Cistanche tubulosa for Cistanche deserticola, or the reverse. Because the food catalogue covers only the desert species, a mislabelled origin becomes a compliance problem immediately.

Closing: From Two Peaks Toward a Complete Profile

Current standards compress the quality of Cistanche into two peaks, echinacoside and acteoside. Two decades ago that was progress, because it gave this botanical its first quantifiable threshold. Measured against today's evidence, however, the same compression has become a constraint: it cannot detect differences in the compounds that act synergistically, and it cannot stop the practice of manufacturing an assay by spiking.

For purchasing and quality control, the executable path is nevertheless clear. Use the statutory parameters as the floor, covering assay, moisture, ash, extractives, heavy metals and pesticide residues. Layer multi-constituent criteria above them, spanning phenylethanoid glycosides, iridoid glycosides, polysaccharides, betaine and mannitol. Use the characteristic chromatogram as the anti-counterfeiting tool. Close the loop with documentation and independent re-testing. Only when these four layers are stacked together has a lot of Cistanche extract actually been seen for what it is.

Principal Source Documents

[1] Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China, 2020 edition, Volume I. Beijing: China Medical Science Press, 2020 (Cistanche monograph: source, description, tests, extractives, assay).

[2] Announcement No. 9 of 2023, National Health Commission and State Administration for Market Regulation, on the addition of nine substances including Codonopsis and Cistanche to the catalogue of materials traditionally used both as food and as Chinese medicinals.

[3] Gansu Provincial Food Safety Local Standard DBS 62/009, Food Safety Local Standard: Cistanche.

[4] Inner Mongolia Autonomous Region Local Standard DB15/T 2360-2021.

[5] Group Standard T/NMSP.MZB01.43-2024, Alxa Desert Cistanche Slices and Edible Cistanche Powder.

[6] Xinjiang Uygur Autonomous Region Drug Administration. Draft standard for Cistanche dispensing granules (Xinjiang Chinese medicine dispensing granule standards).

[7] Guangdong Provincial Drug Administration. Standard for Cistanche dispensing granules.

[8] National Institutes for Food and Drug Control. Method for the assay of Cistanche in Kanggu Zengsheng Tablets.

[9] Beijing University of Chinese Medicine. Desert Ginseng: Cistanche (botanical origin and identification of adulterants).

[10] Analysis of a nationwide sampling inspection of Cistanche decoction pieces (morphological identification and adulteration).